AcQBlate Force Confirmatory Study for Atrial Arrhythmias

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Description

Acutus Medical's AcQBlate Force Ablation Catheter when used in combination with the Qubic Force Sensing Module (AcQBlate Force System), is indicated for cardiac electrophysiological mapping, delivery of diagnostic pacing stimuli, and radiofrequency ablation of sustained or recurrent atrial arrhythmias. ;

NCT number	NCT04429464
Study type	Interventional
Source	Acutus Medical
Contact
Status	Withdrawn
Phase	N/A
Start date	October 1, 2020
Completion date	November 15, 2020

	Status	Clinical Trial	Phase
	Withdrawn	`NCT04512794` - Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation	N/A
	Not yet recruiting	`NCT06452589` - The Field PULSE Study	N/A

AcQBlate Force Confirmatory Study for Atrial Arrhythmias

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms